STRATEGY TO MINIMIZE THE BLEEDING RISKS IN PATIENTS WITH ATRIAL FIBRILLATION WHO RECEIVE COMBINED ANTITHROMBOTIC THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION
The use of combined antithrombotic therapy in patients with atrial fibrillation who underwent percutaneous coronary interventions is associated with an increased risk of bleeding. In this regard, minimizing haemorrhagic risk is one of the strategic priorities in the management of this clinical group...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
«REMEDIUM GROUP» Ltd.
2018-05-01
|
| Col·lecció: | Атеротромбоз |
| Matèries: | |
| Accés en línia: | https://www.aterotromboz.ru/jour/article/view/148 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|